What approaches can be taken when caring for patients with HF who have comorbid T2D and are being considered for new glucose modifying therapies?
When caring for patients with HF who have comorbid T2D and are being considered for new glucose modifying therapies, possible approaches include a consultative approach or a team approach. In a consultative approach, the CV specialist consults with the diabetes clinician and/or the patient in the provision of their care. In a team approach, an interprofessional multidisciplinary group of clinicians (e.g., primary care, endocrinologists, cardiologists, pharmacists, nurses, advanced practice professionals, and dieticians) consider novel therapies collectively.